|本期目录/Table of Contents|

[1]阳文新,何咸兵,王跃华,等.肝移植术后弥漫性脑病的特点及危险因素分析[J].医学研究与战创伤救治(原医学研究生学报),2012,14(05):396-398.
 YANG Wen-xin,HE Xian-bing,WANG Yue-hua,et al.Features of diffuse encephalopathy after liver transplantation and its risk factors[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2012,14(05):396-398.
点击复制

肝移植术后弥漫性脑病的特点及危险因素分析()

《医学研究与战创伤救治》(原医学研究生学报)[ISSN:1672-271X/CN:32-1713/R]

卷:
第14卷
期数:
2012年05期
页码:
396-398
栏目:
出版日期:
2012-09-20

文章信息/Info

Title:
Features of diffuse encephalopathy after liver transplantation and its risk factors
文章编号:
1672-271X(2012)05-0396-03
作者:
阳文新1何咸兵2王跃华3周 斌2于乐成3何长伦3申 红1王 轩3
210002 江苏南京,解放军81医院,1.ICU,2.麻醉科,3.全军肝病中心
Author(s):
YANG Wen-xin1HE Xian-bing2WANG Yue-hua3ZHOU Bin2Yu Yue-cheng3HE Chang-lun3SHEN Hong1WANG Xuan3
1.ICU,2.Department of Anesthesiology,3.Center of Liver Diseases of PLA,81 Hospital of PLA,Nanjing,Jiangsu 210002,China
关键词:
肝移植弥漫性脑病危险因素预后
Keywords:
liver transplantation diffuse encephalopathy risk factors prognosis
分类号:
R657.3
DOI:
-
文献标志码:
A
摘要:
目的 探讨肝移植术后弥漫性脑病(diffuse encephalopathy,DEP)的临床特征、影响因素、防治措施及预后。方法 回顾性分析187例原位肝移植的临床资料,以术后发生DEP者为Ⅰ组,无DEP者为Ⅱ组,比较两组各项临床参数。结果 肝移植术后DEP发生率13.37%。术前Ⅰ组和Ⅱ组慢加急性肝衰竭占48.0%和18.5%(P<0.01);肝功能Child C级占88.0%和65.4%(P<0.05);终末期肝病模型评分为(22.83±10.54)和(13.24±11.36)(P<0.05);总胆红素为(348.6±244.8)μmol/L和(174.3±134.2) μmol/L(P<0.01);血氨为(67.9±24.7)μmol/L和(39.7±14.8)μmol/L(P<0.05)。术中Ⅰ组和Ⅱ组出血量分别为(4108±1513)ml和(3112±1260)ml(P<0.05);平均动脉压<70mmHg例数占92.0%和64.8%(P<0.05);低血压持续时间为(12.4±6.4)min和(7.5±4.6)min(P<0.05);术后Ⅰ组和Ⅱ组病死率为16.0%和4.94%(P<0.05)。结论 肝移植术后DEP与原发病种类及严重度、术中出血量及低血压持续时间、术后免疫抑制剂血药浓度等显著相关。
Abstract:
Objective To investigate the clinical features,influencing factors,prevention measures and prognosis of diffuse encephalopathy (DEP)in patients with orthotopic liver transplantation (OLT).Methods 187 patients with OLT were divided into group Ⅰ with DEP and group Ⅱ without DEP ,and their clinical parameters were retrospectively analyzed.Results Patients of group I accounted for 13.37% of the whole.Before OLT,the percentage of patients in group Ⅰ and Ⅱ diagnosed as acute on chronic liver failure were 48.0% and 18.5% respectively (P<0.01).Patients of Child C accounted for 88.0% and 65.4% respectively (P<0.05).Model for end-stage liver disease score was (22.83±10.54) and (13.24±11.36) (P<0.05).Total serum bilirubin was (348.6±244.8) μmol/L and (174.3±234.2) μmol/L (P<0.01).Serum ammonia was (67.9±24.7) μmol/L and (39.7±14.8) μmol/L (P<0.05).During the OLT operation of group I and II,the volume of blood loss was (4108±1513) ml and (3112±1260) ml (P<0.05).Patients with the MAP less than 70 mmHg were 92.0% and 64.8%(P<0.05),and the duration of hypotension persisted for (12.4±6.4)min and (7.5±4.6)min respectively (P<0.05).After the OLT operation of group I and II,the mortality was 16.0% and 4.94% respectively (P<0.05).Conclusion Liver transplantation postoperative DEP associated with primary disease type and severity,amount of intraoperative bleeding and hypotensive duration,the blood concentration of immunosuppressor,significant correlation.

参考文献/References:

[1]中华医学会传染病与寄生虫病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329.
[2]中华医学会肝病学分会,感染病学分会.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,8(6):881-891.
[3]中国抗癌协会肝癌专业委员会,中华医学会肝病学分会.原发性肝癌规范化诊治专家共识[J].临床肿瘤学杂志,2009,14(3):259-269.
[4]中华医学会感染病学分会,肝病学分会.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646.
[5]金海龙,石炳毅,杜国盛,等.肝移植术后神经系统并发症的临床分析[J].中华肝胆外科杂志,2009,15(2):93-95.
[6]阳文新,钟正江,申 红,等.肝移植术后早期并发症的诊治(附44例报告)[J].东南国防医药,2005,7(3):169-171.
[7]蔡 珺,孙海云,沈 宁,等.肝移植术后脑病患者围手术期脑氧代谢的特点[J].中国危重病急救医学,2011,23(7):396-400.
[8]Kanwal F,Chen D,Ting L,et al.A model to predict the development of mental status changes of unclear cause after liver transplantation[J].Liver Transpl,2003,9(12):1312-1319.
[9]Dawson TM.Immunosuppressants,immunophilins and the nervous system[J].Ann Neurol,1996,40(4):559-560.
[10]许 幂,齐海智,贺志军,等.肝移植术后早期精神并发症病因分析[J].医学临床研究,2008,25(10):1757-1758.
[11]Forgacs B,Merhav HJ,Lappin J,et al.Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation[J].Transplant Proc,2005,37(4):1912-1914.

相似文献/References:

[1]周 斌,何咸兵,段家芳,等.中老年肝移植围手术期的临床分析[J].医学研究与战创伤救治(原医学研究生学报),2012,14(06):507.
 ZHOU Bin,HE Xian-bing,DUAN Jia-fang,et al.Clinical analysis of liver transplantation perioperatively in the aged patients over sixty years of age[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2012,14(05):507.
[2]江 艺,杨 芳,陈少华,等.补救性肝移植治疗小肝癌疗效分析[J].医学研究与战创伤救治(原医学研究生学报),2011,13(02):119.
 JIANG Yi,YANG Fang,CHEN Shao-hua,et al.Salvage liver transplantation for recurrence after resection of small hepatocellular carcinoma[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2011,13(05):119.
[3]蒋玉娣,许凤燕,鲍 磊.肝移植术中的体温护理[J].医学研究与战创伤救治(原医学研究生学报),2011,13(02):164.
[4]李爱梅,郭万华,贾鹏,等.肝癌肝移植术后18F-FDG PET/CT显像特点和预后判断[J].医学研究与战创伤救治(原医学研究生学报),2010,12(05):393.
 LI Ai-mei,GUO Wan-hua,JIA Peng,et al.Imaging of 18F-FDG PET/CT and its value in prediction of prognosis in patients with hepatocellular carcinoma after transplantation[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2010,12(05):393.
[5]赵建生,佟波涛,段加方,等.肝移植术中心跳骤停4例临床初探[J].医学研究与战创伤救治(原医学研究生学报),2009,11(04):326.
 ZHAO Jian-sheng,TONG Bo-tao,DUAN Jia-fang,et al.Clinical analysis of cardiac arrest in 4 cases during liver transplantation[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2009,11(05):326.
[6]蒋玉娣,许凤燕,鲍磊.肝移植术中患者皮肤护理的体会[J].医学研究与战创伤救治(原医学研究生学报),2009,11(05):451.
[7]汪勇,赵武伟,汪朝晖,等.小剂量奥氮平与奋乃静治疗肝移植术后精神障碍的对照研究[J].医学研究与战创伤救治(原医学研究生学报),2016,18(06):572.[doi:10.3969/j.issn.1672-271X.2016.06.004]
 WANG Yong,ZHAO Wu-wei,WANG Zhao-hui,et al.Treatment of patients with mental disorders after liver transplantation by using olanzapine or perphenazine: a control study[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2016,18(05):572.[doi:10.3969/j.issn.1672-271X.2016.06.004]

备注/Memo

备注/Memo:
南京军区“十一五”重点项目资助(09Z011)
更新日期/Last Update: 2012-09-20